Muiños MC, Perez VA, Durán MK

Language: Spanish
References: 14
Page:
PDF size: 391.06 Kb.

ABSTRACT

Stevens-Johnson syndrome is a rare and serious acute inflammatory disease, caused by a hypersensitivity reaction, secondary to medication or infection intake, which affects the skin and mucous membranes, producing characteristic lesions of reactive dermatoses with the presence of vesicles and / or blisters, caused by keratinocyte apoptosis. Its association with dimenhydrate is uncommon. The case of a 9-year-old schoolgirl is presented, with a clinical diagnosis of Stevens-Johnson syndrome, with cutaneous, ocular, genital and oral mucosal manifestations, which began after intake of dimenhydrate. It was maintained with a protocol of care that included the proscription of the drug and the beginning of pharmacological and non-pharmacological measures; After 10 days of hospitalization, the patient progresses satisfactorily without complications during her hospital stay.

REFERENCES

1. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients.JAMA [Internet] 1998 Apr 15 [citado 2019 Dic 19]; 279: 1200-5.

2. TelecheaHéctor, SperanzaNoelia, GiachettoGustavo, Pírez María Catalina. Síndrome de Stevens Johnson: una enfermedad habitualmente producida por medicamentos. ArchPediatrUrug. [Internet] 2008Sep [citado 2020 Feb 01]; 79(3): 229-234

3. Impicciatore P, Choonara I, Clarkson A, Provasi D, PandolfiniC, Bonati M. Incidence of adverse drug reactions in paediatric in/out-patients:a systematic review and metaanalysis of prospective studies. Br J ClinPharmacol [Internet] 2001 Jul [citado 2020 Feb 01 ]; 52: 77-83

4. Alvarado et al. Reporte de un caso clínico y revisión: Síndrome de Stevens Johnson por uso de Lamotrigina. Pediátr Panamá [Internet] 2018 [citado 2019 Dic 19]; 47 (3): 29-36

5. Stevens AM, Johnson FC. A new eruptive fever associated with stomatitis and ophtalmia: report of two cases in children. Am J DisChild. [Internet] 1922 [citado 2020 Feb 01]; 24: 526-533.

6. Paredes P, et al. (2018) Síndrome de Stevens-Johnson en edad pediátrica. Revista científica INSPILIP [Internet] [citado 2019 Dic 19]Volumen. (2), Número 1, Guayaquil, Ecuador

7. Estrella-Alonso A, et al. Toxic epidermal necrolysis: a paradigm of critical illness. RevBras Ter Intensiva. [Internet] 2017 [citado 2020 Feb 01];29(4):499-508.

8. Acajabón, Mónica Vanessa Vasquez. Médico y Cirujano. Tesis doctoral. Diss. Universidad de San Carlos de Guatemala, 2015 [Internet. Citado 2019 Dic 19]

9. Arenas R. Dermatosis reacciónales. En: Arenas R. Atlas dermatología, diagnóstico y tratamiento. 3 ed. México: Mc Graw-Hill Interamericana; 2005: p. 59-62 [Internet. Citado 2020 Feb 01]

10. Lerch M, Mainetti C, Terziroli Beretta-Piccoli B, Harr T. Current Perspectives on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis. ClinRevAllergyImmunol. [Internet] 2018 [citado 2020 Feb 01]; 54(1): 147-176

11. Bonilla-Rojas J, Hernández-Cabezza A, Villasís-Keever MA, Serret-Montoya J, Cárdenas-Navarrete R. Síndrome de Stevens-Johnson en pediatría, reporte de un caso por el uso de antiepilépticos. RevMexPediatr[Internet] 2018 [citado 2019 Dic 19]; 85(6):226-229.

12. Mockenhaupt M, et al. Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study. J Invest Dermatol. [Internet] 2008 Jan [citado 2020 Feb 01];128(1):35-44.Epub 2007 Sep 6.

13. Palencia, B. Angélica, et al. ‘’Dimenhidrato como causa de síndrome de Stevens-Johnson’’. Acta Médica Colombiana, vol. 41, no. 3 S1, 2016, p.96. Gale AcademicOnefile, [Internet. Accessed 2019 Dec 19].

14. Machin, Y. (2015). Complicaciones oftalmológicas tardías del síndrome de Stevens- Johnson. Presentación de caso. Revista Habanera de Ciencias Médicas [Internet. Citado 2020 Feb 01];13(4):580-585. Recuperado de http://scielo.sld.cu/pdf/rhcm/v13n4/rhcm09414.pdf